Menu Back to Latin-America-Regulatory-Conference


DIA brings you a symposium with interactive dynamics, where you will engage in discussions with key stakeholders influencing the advancement and implementation of regulatory convergence initiatives in Latin America. Join us to discuss multi-regional cooperation, global harmonization, and best practices related to Latin America’s regulatory landscape.
Sessions will highlight regulatory approaches and good practices to ensure reliance in Latin American and strategic initiatives to improve collaboration and cooperation.

We will be translating:

  • English to Spanish and Portuguese
  • Spanish to English and Portuguese
  • Portuguese to English and Spanish

DIA can provide a letter to confirm your onsite participation as long as you have:

  • Already registered for this conference and
  • Paid the registration for this conference

To request a confirmation letter please send an email to Megan Stevens at

On-Demand Content Preview Webinar

The US FDA Generic Drug Program – The Framework to "Sameness"
Gain an overview of the legal framework for how generic drugs can be developed for approval in the United States, and more.
Register today.

New Podcast!

Promoting Patient-Centric Business: MedComm in Latin America
Hear Barbara Nardi, Associate Director of Medical Communications, PPD, Brazil, and Emanuela Lopes Fernandes Saraiva, Customer Service and Medical Information Manager in Pharmacovigilance, Libbs Farmaceutica, Brazil, discuss topics from DIA's Latin America Medical Information and Communication Workshop.
Listen in.


Want to learn more about Latin America Regulatory Conference? You've come to the right site!

Continuing Education

Learn more


Learn more

Who should attend?

Professionals involved in:

  • Drug regulation
  • Clinical research and development
  • Medical and scientific affairs
  • Quality assurance
  • Research and development
  • Strategic sourcing/planning
  • Regulatory affairs

Learning objectives

At the conclusion of this conference, participants should be able to:

  • Discuss various initiatives related to global regulatory convergence and harmonization and their impact on the access of medicines and future R&D in Latin America
  • Examine various approaches and best practices to ensure regulatory reliance in Latin America

Program Committee

  • Mario  Alanis, PhD
    Mario Alanis, PhD Senior Advisor
    Centre for Innovation in Regulatory Science (CIRS), United Kingdom
  • Peter  Baker
    Peter Baker International Relations Specialist, OIP, OGROP
    FDA, United States
  • Maria  Guazzaroni Jacobs, PhD
    Maria Guazzaroni Jacobs, PhD Director, Quality Intelligence, Global Supply
    Pfizer Inc, United States
  • Maria Cristina  Mota Pina, MBA
    Maria Cristina Mota Pina, MBA Director, Regulatory Policy and Intelligence -Japan, Emerging Markets, Australia
    Latin America Federation of Pharmaceutical Industry (FIFARMA), United States
  • Jaime  Oliveira, DrPH, AHIP
    Jaime Oliveira, DrPH, AHIP Head Regulatory Policy and Intelligence LatAm
    Bayer S.A., Brazil
  • Patricia  Oliveira Pereira Tagliari, LLM, MPH
    Patricia Oliveira Pereira Tagliari, LLM, MPH Associate Director
    Brazilian Health Regulatory Agency - ANVISA, Brazil
  • Ana  Padua, MSc, RPh
    Ana Padua, MSc, RPh Associate Director GRA CMC Regulatory Intelligence Biopharam Global Regulatory
    EMD Serono, Switzerland
  • Ana  Pineda Zavaleta, MSc
    Ana Pineda Zavaleta, MSc International Regulatory Analyst, OIP, OGROP, OC
    FDA, United States
  • Analia  Porras
    Analia Porras Unit Chief, Medicines and Health Technologies
    Pan American Health Organization (PAHO), United States
Load More

Contact us

Registration Questions?

Send Email

Digital Learning Catalog

DIA Learning: eLearning Soultions